Tuor U I, Simone C S, Barks J D, Post M
Department of Pediatrics, University of Toronto, Canada.
Stroke. 1993 Mar;24(3):452-7. doi: 10.1161/01.str.24.3.452.
We recently demonstrated that pretreatment with the synthetic glucocorticoid dexamethasone prevents hypoxic-ischemic brain damage in neonatal rats. Presently, we examine whether this protective effect of dexamethasone is due to an improvement in local cerebral blood flow.
Neonatal rats were treated with either vehicle or 0.1 mg/kg i.p. dexamethasone 24 hours before hypoxia-ischemia (right carotid artery occlusion +3 hours of 8% O2). Cerebral blood flow was measured with [14C]iodoantipyrine autoradiography after either 2 (n = 17) or 3 (n = 15) hours of hypoxia-ischemia. Additional animals (n = 20) were perfusion-fixed 3 days after hypoxia-ischemia. The area of cerebral pathological changes was measured from hematoxylin and eosin-stained coronal sections taken at three different levels.
Pathological outcome differed between groups. In vehicle-treated rats, sections from anterior, mid, and posterior portions of the cerebrum all had extensive infarction or cellular necrosis ipsilateral to the occlusion (mean areas of damage were 62.6 +/- 10%, 70.2 +/- 9%, and 54.2 +/- 8%, respectively). However, in dexamethasone-treated animals, brain damage in sections at corresponding levels was minimal (0%, 1.6 +/- 2%, and 1.5 +/- 1%, respectively; p < 0.0002). In contrast to the pathological results, cerebral blood flow was equivalent in the dexamethasone- and vehicle-treated groups. After either 2 or 3 hours of hypoxia, cerebral blood flow was reduced 60-80% ipsilateral to the carotid artery occlusion in animals treated with either vehicle or dexamethasone.
Despite ischemic levels of cerebral blood flow, pretreatment with dexamethasone prevents cerebral damage in neonatal rats. Instead of improving local cerebral perfusion, dexamethasone presumably acts via peripheral or central glucocorticoid receptors to produce some alteration in the brain that decreases its susceptibility to hypoxia-ischemia.
我们最近证实,用合成糖皮质激素地塞米松进行预处理可预防新生大鼠的缺氧缺血性脑损伤。目前,我们研究地塞米松的这种保护作用是否归因于局部脑血流的改善。
在缺氧缺血(右颈动脉闭塞+8%氧气环境下3小时)前24小时,给新生大鼠腹腔注射溶剂或0.1mg/kg地塞米松。在缺氧缺血2小时(n = 17)或3小时(n = 15)后,用[14C]碘安替比林放射自显影法测量脑血流量。另外20只动物在缺氧缺血3天后进行灌注固定。从三个不同水平获取的苏木精-伊红染色冠状切片测量脑病理变化面积。
各组间病理结果不同。在注射溶剂的大鼠中,大脑前、中、后部分的切片在闭塞同侧均有广泛梗死或细胞坏死(平均损伤面积分别为62.6±10%、70.2±9%和54.2±8%)。然而,在地塞米松处理的动物中,相应水平切片的脑损伤最小(分别为0%、1.6±2%和1.5±1%;p < 0.0002)。与病理结果相反,地塞米松处理组和注射溶剂组的脑血流量相当。在缺氧2小时或3小时后,注射溶剂或地塞米松的动物在颈动脉闭塞同侧的脑血流量减少60 - 80%。
尽管脑血流处于缺血水平,但用地塞米松预处理可预防新生大鼠的脑损伤。地塞米松可能不是通过改善局部脑灌注起作用,而是通过外周或中枢糖皮质激素受体发挥作用,在大脑中产生某种改变,降低其对缺氧缺血的易感性。